Eliane Gefen, Nathalie H Launder, Christopher G Davey, Mor Nahum, Yafit Gilboa, Carsten Finke, Hanna Malmberg Gavelin, Nicola T Lautenschlagera, Amit Lampit
{"title":"Computerized Cognitive Training in People with Depression: A Systematic Review and Meta-analysis of Randomized Clinical Trials.","authors":"Eliane Gefen, Nathalie H Launder, Christopher G Davey, Mor Nahum, Yafit Gilboa, Carsten Finke, Hanna Malmberg Gavelin, Nicola T Lautenschlagera, Amit Lampit","doi":"10.1159/pps/aemag019","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cognitive impairment and depression frequently co-occur, exacerbating disability. Identifying accessible interventions to enhance cognition in people with depression is imperative. Computerized cognitive training (CCT) is a potential strategy, but its clinical efficacy across settings remain unclear. We investigated the efficacy of CCT and potential moderators of cognitive and functional outcomes in individuals with depressive symptoms.</p><p><strong>Methods: </strong>In this systematic review and meta-analysis (PROSPERO: CRD42020204209), we searched MEDLINE, Embase, and PsycINFO from inception to June 22, 2026 for randomized controlled trials (RCTs) of CCT in adults (≥18 years) with clinically significant depressive symptoms. Primary outcome was change in overall cognition. Secondary outcomes included depressive symptoms, psychosocial and daily functioning.</p><p><strong>Results: </strong>Fifty-three 53 RCTs (3831 participants) were included. CCT was efficacious for overall cognition (49 RCTs, (g=0.23; 95% CI 0.14 to 0.32; τ2=0.095) and depressive symptoms (35 RCTs, g=0.22; 95% CI 0.08 to 0.37; τ2=0.066) with substantial heterogeneity across studies, and did not extend to psychiatric symptoms and daily function. Greater cognitive benefits were associated with multidomain training, higher doses, session durations >30 min, and ≤3 sessions per week. Efficacy was independent of baseline symptom severity, and comparable across delivery modes.</p><p><strong>Conclusions: </strong>CCT can improve cognition, depression and subjective outcomes in people with major or comorbid depression, but efficacy varies across outcomes, settings and intervention design factors. Future work is needed to confirm these factors, and examine what approaches and dose is required to enhance cognitive and functional outcomes of CCT.</p>","PeriodicalId":20744,"journal":{"name":"Psychotherapy and Psychosomatics","volume":" ","pages":"1"},"PeriodicalIF":9.0000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychotherapy and Psychosomatics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/pps/aemag019","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Cognitive impairment and depression frequently co-occur, exacerbating disability. Identifying accessible interventions to enhance cognition in people with depression is imperative. Computerized cognitive training (CCT) is a potential strategy, but its clinical efficacy across settings remain unclear. We investigated the efficacy of CCT and potential moderators of cognitive and functional outcomes in individuals with depressive symptoms.
Methods: In this systematic review and meta-analysis (PROSPERO: CRD42020204209), we searched MEDLINE, Embase, and PsycINFO from inception to June 22, 2026 for randomized controlled trials (RCTs) of CCT in adults (≥18 years) with clinically significant depressive symptoms. Primary outcome was change in overall cognition. Secondary outcomes included depressive symptoms, psychosocial and daily functioning.
Results: Fifty-three 53 RCTs (3831 participants) were included. CCT was efficacious for overall cognition (49 RCTs, (g=0.23; 95% CI 0.14 to 0.32; τ2=0.095) and depressive symptoms (35 RCTs, g=0.22; 95% CI 0.08 to 0.37; τ2=0.066) with substantial heterogeneity across studies, and did not extend to psychiatric symptoms and daily function. Greater cognitive benefits were associated with multidomain training, higher doses, session durations >30 min, and ≤3 sessions per week. Efficacy was independent of baseline symptom severity, and comparable across delivery modes.
Conclusions: CCT can improve cognition, depression and subjective outcomes in people with major or comorbid depression, but efficacy varies across outcomes, settings and intervention design factors. Future work is needed to confirm these factors, and examine what approaches and dose is required to enhance cognitive and functional outcomes of CCT.
期刊介绍:
Psychotherapy and Psychosomatics is a reputable journal that has been published since 1953. Over the years, it has gained recognition for its independence, originality, and methodological rigor. The journal has been at the forefront of research in psychosomatic medicine, psychotherapy research, and psychopharmacology, and has contributed to the development of new lines of research in these areas. It is now ranked among the world's most cited journals in the field.
As the official journal of the International College of Psychosomatic Medicine and the World Federation for Psychotherapy, Psychotherapy and Psychosomatics serves as a platform for discussing current and controversial issues and showcasing innovations in assessment and treatment. It offers a unique forum for cutting-edge thinking at the intersection of medical and behavioral sciences, catering to both practicing clinicians and researchers.
The journal is indexed in various databases and platforms such as PubMed, MEDLINE, Web of Science, Science Citation Index, Social Sciences Citation Index, Science Citation Index Expanded, BIOSIS Previews, Google Scholar, Academic Search, and Health Research Premium Collection, among others.